StockData
Cullinan Therapeutics, Inc. logo

Cullinan Therapeutics, Inc. (CGEM) stock

CGEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$9.01−0.27 (-2.86%)

Close on Nov 18, 2026Market cap $579.84MP/E –Yield –

Cullinan Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Cullinan Therapeutics's price to book ratio was 1.9× on Apr 30, 2026, against 0.8× a year earlier. Over the last 5 years it ranged from 0.7× to 2.8×, with a median of 1.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 20261.9×+0.6
2025Dec 31, 20251.4×+0.2
2024Dec 31, 20241.1×+0.2
2023Dec 29, 20230.9×+0.1
2022Dec 30, 20220.8×−0.7
2021Dec 31, 20211.5×–

More Cullinan Therapeutics figures

See a number that looks wrong?